pentoxifylline has been researched along with Amentia in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " It covers firstly the general problems of stroke, dementia and 'common symptoms' of the elderly, and then looks in detail at those compounds which have to date attracted most attention (ergot derivatives, cinnarizine, flunarizine, vincamine, eburnamonine, naftidrofuryl, oxpentifylline, piracetam and citicoline), as well as those which are currently considered investigational (choline and lecithin)." | 6.15 | 'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders. ( Spagnoli, A; Tognoni, G, 1983) |
| "Twenty outpatients (8 women and 12 men; age range 52-66 years) with mild to moderate degree of cerebrovascular disorders and arteriosclerotic dementia, were randomly assigned to either control or pentoxifylline group (400 mg X 3/day/4 weeks p." | 5.05 | Cerebral blood flow in patients with cerebrovascular disorders: study with pentoxifylline. ( Hartmann, A, 1981) |
| "At present there is no therapy for Alzheimer's Disease which completely stops the progressive dementia effecting late onset Alzheimer's Disease (AD) patients." | 1.46 | A unique and promising combination of medications for the treatment of Alzheimer's disease. ( Weinstein, JD, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weinstein, JD | 1 |
| Spagnoli, A | 1 |
| Tognoni, G | 1 |
| Hartmann, A | 2 |
| Ghose, K | 1 |
| Parnetti, L | 2 |
| Ciuffetti, G | 2 |
| Mercuri, M | 2 |
| Lupattelli, G | 1 |
| Senin, U | 2 |
| Hollister, LE | 1 |
1 review available for pentoxifylline and Amentia
| Article | Year |
|---|---|
'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.
Topics: Adult; Aged; Cerebrovascular Disorders; Cinnarizine; Clinical Trials as Topic; Cytidine Diphosphate | 1983 |
6 trials available for pentoxifylline and Amentia
| Article | Year |
|---|---|
'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.
Topics: Adult; Aged; Cerebrovascular Disorders; Cinnarizine; Clinical Trials as Topic; Cytidine Diphosphate | 1983 |
Cerebral blood flow in patients with cerebrovascular disorders: study with pentoxifylline.
Topics: Aged; Cerebrovascular Circulation; Dementia; Female; Humans; Intracranial Arteriosclerosis; Male; Mi | 1981 |
Oxpentifylline in dementia: a controlled study.
Topics: Aged; Dementia; Double-Blind Method; Female; Humans; Male; Mental Processes; Mental Status Schedule; | 1987 |
The role of haemorheological factors in the ageing brain: long-term therapy with pentoxifylline ('Trental' 400) in elderly patients with initial mental deterioration.
Topics: Aged; Aging; Blood Viscosity; Cerebrovascular Circulation; Dementia; Erythrocyte Deformability; Fema | 1986 |
Haemorheological pattern in initial mental deterioration: results of a long-term study using piracetam and pentoxifylline.
Topics: Aged; Clinical Trials as Topic; Dementia; Drug Therapy, Combination; Female; Humans; Male; Mental Re | 1985 |
Comparative randomized study of cerebral blood flow after long-term administration of pentoxifylline and co-dergocrine mesylate in patients with chronic cerebrovascular disease.
Topics: Aged; Blood Flow Velocity; Cerebrovascular Circulation; Dementia; Dihydroergotoxine; Female; Humans; | 1985 |
2 other studies available for pentoxifylline and Amentia
| Article | Year |
|---|---|
A unique and promising combination of medications for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Dementia; Disease Progression; Drug Design; Drug Therapy, Combination; Hum | 2017 |
Alzheimer's disease. Is it worth treating?
Topics: Aged; Alzheimer Disease; Dementia; Dihydroergotoxine; Humans; Nafronyl; Papaverine; Pentoxifylline; | 1985 |